NVE-02

About Noveeda

Noveeda is a private, pre-revenue biopharma company developing a pipeline of needle-free emergency medicines. Its lead product, Nasefrin, is an intranasal epinephrine formulation for anaphylaxis, currently in preclinical development with key milestones targeted for 2025-2027. The company combines an experienced international executive team with a scientific R&D center in Czechia to advance its portfolio targeting conditions like poisoning, seizures, and hypoglycemia.

Therapeutic Areas